Matches in Nanopublications for { ?s ?p "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1148570.RAZs6ZlYzrkDDDMRHf7MeKrrGtC6uwAR-c5cs-YtshyKQ130_assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148570.RAZs6ZlYzrkDDDMRHf7MeKrrGtC6uwAR-c5cs-YtshyKQ130_provenance.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.